GASTROESOPHAGEAL JUNCTION (GEJ) CANCERS

Clinical trials for GASTROESOPHAGEAL JUNCTION (GEJ) CANCERS explained in plain language.

Never miss a new study

Get alerted when new GASTROESOPHAGEAL JUNCTION (GEJ) CANCERS trials appear

Sign up with your email to follow new studies for GASTROESOPHAGEAL JUNCTION (GEJ) CANCERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Supercharged immune cells join the fight against tough cancers

Disease control Ongoing

This study is testing a new combination of three immune-based treatments for adults with advanced stomach or head and neck cancer that has returned or spread after standard therapy. The treatment involves giving patients specially engineered immune cells (CAR-NK cells) along with…

Matched conditions: GASTROESOPHAGEAL JUNCTION (GEJ) CANCERS

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 27, 2026 12:41 UTC

GASTROESOPHAGEAL JUNCTION (GEJ) CANCERS

Get alerted when new GASTROESOPHAGEAL JUNCTION (GEJ) CANCERS trials appear

Supercharged immune cells join the fight against tough cancers